TERN - Financial Reports List - Terns Pharmaceuticals, Inc. - IntrinsicAlpha

Terns Pharmaceuticals, Inc. TERN

Healthcare - Biotechnology - NASDAQ - US

$ 2.785

12.9 %

$ 243 M

Market Cap

-2.42

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	0.00%	-3.71%	-7.86%
Annual Report	FY	10-K	2024-12-31	0.00%	1.50%	0.67%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	26.28%	24.85%
Quarterly Report	Q2	8-K	2024-06-30	0.00%	-27.05%	-20.69%
Quarterly Report	Q1	8-K	2024-03-31	0.00%	-3.93%	-5.34%
Quarterly Report	Q4	8-K	2023-12-31	0.00%	-32.85%	-42.96%
Annual Report	FY	10-K	2023-12-31	0.00%	-49.49%	-65.34%
Quarterly Report	Q3	8-K	2023-09-30	0.00%	-76.97%	-91.90%
Quarterly Report	Q2	8-K	2023-06-30	0.00%	-28.47%	-50.23%
Quarterly Report	Q1	8-K	2023-03-31	0.00%	-56.31%	-74.73%

1